CoreCivic, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CoreCivic, Inc. (NYSE: CXW) on May 15, 2025. The filing reports on corporate governance updates, the results of the 2025 Annual Meeting of Stockholders, and an expansion of the company's share repurchase program.
Key Financial Metrics and Capital Allocation
The filing does not provide revenue, profit, cash flow, or margin data. Key capital allocation metrics include:
- Share Repurchase Authorization: The Board authorized an additional $150.0 million, increasing the total program authorization to $500.0 million.
- Historical Repurchases: From May 16, 2022, through May 14, 2025, the company repurchased 16.6 million shares at an average price of approximately $13.36 per share, totaling $222.1 million.
- Remaining Authorization: Approximately $277.9 million remains available under the current plan.
Material Changes and Corporate Actions
Significant events reported in this filing include:
- Code of Ethics Amendment: The Board approved a new Code of Ethics effective by or before the third quarter of 2025. The update emphasizes human rights, integrity as a government contractor, and workplace safety. It does not materially change previous responsibilities or result in any waivers.
- Annual Meeting Results: The meeting was held via webcast with 84.4% of outstanding shares represented. Stockholders elected all 12 director nominees, ratified Ernst & Young LLP as the independent auditor, and approved the advisory vote on executive compensation.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the share repurchase program, noting that actual results may differ due to risks described in the company's 2024 Form 10-K. The repurchase program has no time limit and does not obligate the company to purchase a specific amount of stock. The Board retains discretion to terminate, suspend, or modify the program at any time.
Investor Verification Checklist
- Verify the specific vote counts for director nominees, particularly those with higher "Against" vote totals (e.g., John R. Prann, Jr. and Thurgood Marshall, Jr.).
- Confirm the exact effective date of the new Code of Ethics once implemented in Q3 2025.
- Monitor future 8-K filings for actual execution of the $277.9 million remaining share repurchase authorization.
- Review the 2024 Form 10-K for detailed risk factors referenced in the forward-looking statements.